TransCode Therapeutics Inc. (RNAZ)

Last Closing Price: 7.97 (2025-06-27)

Pre-Tax Income (Quarterly)

Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.

TransCode Therapeutics Inc. (RNAZ) had Pre-Tax Income of $-12.09M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-12.09M
--
--
$3.17M
$-3.17M
$-8.91M
Pre-Tax Income
$-12.09M
$-12.09M
$-12.09M
$-12.09M
$-12.09M
$-12.09M
$-3.17M
$-3.12M
0.17M
0.17M
$-70.31
$-70.31
Balance Sheet Financials
$13.04M
$0.04M
$0.15M
$13.19M
$2.51M
--
$0.39M
$2.90M
$10.29M
$10.29M
$10.29M
0.83M
Cash Flow Statement Financials
$-3.10M
--
$8.85M
$5.81M
$11.57M
$5.76M
$0.16M
--
--
Fundamental Metrics & Ratios
5.20
--
--
--
--
--
--
--
--
--
--
$-3.10M
--
--
--
--
--
--
--
-117.42%
-117.42%
-91.60%
-117.42%
$12.35
$-17.98
$-17.98